CIK 0001520262 · Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981007018
- Phone
- 00-353-1-772-8000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,070,874
- in 5 filings, $1.1M under 10b5-1 plans
Net −$1,070,874. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-02 | Cooke Shane Director | Option exercise | +10,000 | $16.55 | $166K | 100,478 |
| 2022-05-02 | Cooke Shane Director | Sale | −10,000 | $29.23 | $292K | 90,478 |
| 2022-05-02 | Cooke Shane Director | Option exercise · Employee Stock Option (Right to Buy) | −10,000 | 0 | ||
| 2022-04-25 | Cooke Shane Director | Option exercise | +10,000 | $16.55 | $166K | 100,478 |
| 2022-04-25 | Cooke Shane Director | Sale | −10,000 | $27.88 | $279K | 90,478 |
| 2022-04-25 | Cooke Shane Director | Option exercise · Employee Stock Option (Right to Buy) | −10,000 | 10,000 | ||
| 2022-04-20 | Jackson Blair Curtis EVP, Chief Operating Officer | Option exercise | +49,999 | $16.55 | $827K | 137,914 |
| 2022-04-20 | Jackson Blair Curtis EVP, Chief Operating Officer | Sale | −49,999 | $29.61 | $1.5M | 87,915 |
| 2022-04-20 | Jackson Blair Curtis EVP, Chief Operating Officer | Option exercise · Employee Stock Option (Right to Buy) | −49,999 | 0 | ||
| 2022-04-18 | Cooke Shane Director | Option exercise | +10,000 | $16.55 | $166K | 100,478 |
| 2022-04-18 | Cooke Shane Director | Sale | −10,000 | $28.88 | $289K | 90,478 |
| 2022-04-18 | Cooke Shane Director | Option exercise · Employee Stock Option (Right to Buy) | −10,000 | 20,000 | ||
| 2022-04-11 | Cooke Shane Director | Option exercise | +10,000 | $16.55 | $166K | 100,478 |
| 2022-04-11 | Cooke Shane Director | Sale | −10,000 | $29.26 | $293K | 90,478 |
| 2022-04-11 | Cooke Shane Director | Option exercise · Employee Stock Option (Right to Buy) | −10,000 | 30,000 | ||
| 2022-04-04 | Cooke Shane Director | Option exercise | +10,000 | $16.55 | $166K | 100,478 |
| 2022-04-04 | Cooke Shane Director | Sale | −10,000 | $28.18 | $282K | 90,478 |
| 2022-04-04 | Cooke Shane Director | Option exercise · Employee Stock Option (Right to Buy) | −10,000 | 40,000 | ||
| 2022-03-04 | snyderman nancy lynn MD Director | Purchase | +427 | $23.43 | $10K | 9,366 |
| 2022-02-23 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Sale | −11,983 | $24.76 | $297K | 17,994 |
Page 52 of 60 · 1,194 trades